Barclays logo
Barclays

May 28, 2026

Americas Morning Research Summary

Market ReportEquitiesDerivativesFinancialsHealth Care

A comprehensive daily summary of rating changes and research highlights across the Americas, focusing on biotech initiations, bank earnings, and AI-driven infrastructure shifts.

Key Takeaways

  • 1.Barclays initiated coverage on four oncology platform stocks (Alpha Tau, Cellectis, Immunome, and Sutro Biopharma) all with Overweight ratings.
  • 2.Major Canadian banks (BMO, BNS, NA) reported 2Q26 results tracking toward ROE targets of 14-17% by fiscal year 2027.
  • 3.Cloud security firms including CrowdStrike, Zscaler, and Cloudflare are raising CapEx guidance due to rising memory and component costs.

Table of Contents

  • Summary of Changes
  • Consumer
  • Energy
  • Financial Services
  • Healthcare
  • Industrials
  • Internet & Media
  • Retail
  • Technology
  • Thematic Investing
  • Derivatives

Document Preview

Page 1 of 5
Page 1 of Americas Morning Research Summary
Subscribe for full access

Access the Full Report

Get unlimited access to institutional research reports with a 14-day free trial.

Authors

Andrew LazarBrian MortonLuke SergottSaket Kalia

Securities

DRTSBMO.TOCRMSNOWCRWDTSLA

Themes

AI Infrastructure ShiftOncology Platform DifferentiationPost-Earnings Estimate Revisions

Regions

North AmericaAsia PacificEuropeUnited StatesCanadaChina